发明申请
- 专利标题: TISSUE-ENGINEERED CONSTRUCTS
-
申请号: US15974195申请日: 2018-05-08
-
公开(公告)号: US20180251727A1公开(公告)日: 2018-09-06
- 发明人: Shannon L.M. DAHL , Laura E. NIKLASON , Justin T. STRADER , William E. TENTE , Joseph J. LUNDQUIST
- 申请人: Humacyte, Inc.
- 申请人地址: US NC Durham
- 专利权人: Humacyte, Inc.
- 当前专利权人: Humacyte, Inc.
- 当前专利权人地址: US NC Durham
- 主分类号: C12N5/00
- IPC分类号: C12N5/00 ; A61F2/04 ; A61F2/06 ; B29C53/00 ; B29C53/36 ; A61L27/34 ; B29K105/00 ; B29K67/00 ; B29L23/00 ; B29L31/00
摘要:
The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
公开/授权文献
- US10934522B2 Tissue-engineered constructs 公开/授权日:2021-03-02
信息查询